Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
155.5 EUR | -0.93% | -1.16% | -12.30% |
29/05 | Transcript : Zoetis Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 12:05 PM | |
23/05 | Declaration of Voting Results by Zoetis Inc | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.96 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.30% | 77.37B | - | ||
+18.66% | 8.74B | B- | ||
+23.75% | 3.67B | B- | ||
-0.42% | 3.25B | B- | ||
+18.07% | 1.73B | - | ||
-16.99% | 1.38B | B | ||
-0.39% | 1.31B | - | ||
-26.05% | 1.24B | C- | ||
-17.86% | 1.07B | - | ||
-6.77% | 976M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ZTS Stock
- ZOE Stock
- Ratings Zoetis Inc.